BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23525755)

  • 1. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
    Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
    Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    Jaeckle KA; Phuphanich S; Bent MJ; Aiken R; Batchelor T; Campbell T; Fulton D; Gilbert M; Heros D; Rogers L; O'Day SJ; Akerley W; Allen J; Baidas S; Gertler SZ; Greenberg HS; LaFollette S; Lesser G; Mason W; Recht L; Wong E; Chamberlain MC; Cohn A; Glantz MJ; Gutheil JC; Maria B; Moots P; New P; Russell C; Shapiro W; Swinnen L; Howell SB
    Br J Cancer; 2001 Jan; 84(2):157-63. PubMed ID: 11161370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
    Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
    J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
    Benesch M; Siegler N; Hoff Kv; Lassay L; Kropshofer G; Müller H; Sommer C; Rutkowski S; Fleischhack G; Urban C
    Anticancer Drugs; 2009 Oct; 20(9):794-9. PubMed ID: 19617818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
    Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
    Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
    Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
    Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
    Craig C
    Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].
    Silvani A
    Tumori; 2007; 93(3):suppl 6-8. PubMed ID: 17679480
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
    Phuphanich S; Maria B; Braeckman R; Chamberlain M
    J Neurooncol; 2007 Jan; 81(2):201-8. PubMed ID: 16941075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
    Kripp M; Hofheinz RD
    Int J Nanomedicine; 2008; 3(4):397-401. PubMed ID: 19337408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
    Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].
    Pace A
    Tumori; 2007; 93(3):suppl 9-12. PubMed ID: 17679481
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
    Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
    J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.